UCB SA Financials

UCBJY Stock  USD 58.22  1.22  2.14%   
Financial data analysis helps to confirm if markets are today mispricing UCB SA ADR. We are able to break down thirty-six available financial indicators for UCB SA, which can be compared to its peers in the sector. To ensure the equity is not overpriced, please validate all UCB SA ADR financials, including its price to sales, earnings per share, five year return, as well as the relationship between the cash per share and retained earnings . Given that UCB SA ADR has a price to sales of 2.54 X, we advise you to double-check UCB SA latest market performance to make sure the company can sustain itself for few more years. The stock experiences an expected bullish sentiment for its category. Check odds of UCB SA to be traded at $69.86 in 90 days.
With this module, you can analyze UCB financials for your investing period. You should be able to track the changes in UCB SA individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past UCB SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of UCB SA's financial statements are interrelated, with each one affecting the others. For example, an increase in UCB SA's assets may result in an increase in income on the income statement.
Evaluating UCB SA's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of UCB SA's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the UCB SA's relative financial performance

Chance Of Distress

Less than 12

 
100  
 
Zero
Low
UCB SA ADR has less than 12 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for UCB SA pink sheet is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, UCB SA's odds of distress score SHOULD NOT be confused with the real chance of UCB SA ADR filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as UCB is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include UCB SA's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in UCB SA's official financial statements usually reflect UCB SA's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of UCB SA ADR. For example, before you start analyzing numbers published by UCB accountants, it's critical to develop an understanding of what UCB SA's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of UCB SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, UCB SA's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in UCB SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of UCB SA ADR. Please utilize our Beneish M Score to check the likelihood of UCB SA's management manipulating its earnings.

UCB SA Company Summary

UCB SA competes with Pearson PLC, Moderna, Vertex Pharmaceuticals, Novo Nordisk, and Regeneron Pharmaceuticals. UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. UCB S operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS9034801012
Business AddressAlle de la
SectorHealthcare
IndustryBiotechnology
BenchmarkNYSE Composite
Websitewww.ucb.com
Phone32 2 559 99 99
CurrencyUSD - US Dollar
You should never invest in UCB SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of UCB Pink Sheet, because this is throwing your money away. Analyzing the key information contained in UCB SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

UCB SA Key Financial Ratios

Generally speaking, UCB SA's financial ratios allow both analysts and investors to convert raw data from UCB SA's financial statements into concise, actionable information that can be used to evaluate the performance of UCB SA over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that UCB SA ADR reports annually and quarterly.

UCB Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining UCB SA's current stock value. Our valuation model uses many indicators to compare UCB SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UCB SA competition to find correlations between indicators driving UCB SA's intrinsic value. More Info.
UCB SA ADR is rated first in net income category among related companies. It is rated first in operating margin category among related companies . The ratio of Net Income to Operating Margin for UCB SA ADR is about  5,636,654,235 . Comparative valuation analysis is a catch-all model that can be used if you cannot value UCB SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for UCB SA's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UCB SA's earnings, one of the primary drivers of an investment's value.

UCB SA ADR Systematic Risk

UCB SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. UCB SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on UCB SA ADR correlated with the market. If Beta is less than 0 UCB SA generally moves in the opposite direction as compared to the market. If UCB SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one UCB SA ADR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of UCB SA is generally in the same direction as the market. If Beta > 1 UCB SA moves generally in the same direction as, but more than the movement of the benchmark.

About UCB SA Financials

What exactly are UCB SA Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include UCB SA's income statement, its balance sheet, and the statement of cash flows. Potential UCB SA investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although UCB SA investors may use each financial statement separately, they are all related. The changes in UCB SA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on UCB SA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze UCB SA Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as UCB SA is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of UCB has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if UCB SA's financials are consistent with your investment objective using the following steps:
  • Review UCB SA's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand UCB SA's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare UCB SA's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if UCB SA's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

UCB SA March 19, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of UCB SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of UCB SA ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of UCB SA ADR based on widely used predictive technical indicators. In general, we focus on analyzing UCB Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build UCB SA's daily price indicators and compare them against related drivers.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UCB SA ADR. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for UCB Pink Sheet analysis

When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Please note, there is a significant difference between UCB SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if UCB SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UCB SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.